{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:17:44Z","timestamp":1791325064582,"version":"4.3.1"},"reference-count":72,"publisher":"American Chemical Society (ACS)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bioconjugate Chem."],"published-print":{"date-parts":[[2007,1,1]]},"DOI":"10.1021\/bc0601471","type":"journal-article","created":{"date-parts":[[2006,11,29]],"date-time":"2006-11-29T19:08:06Z","timestamp":1164827286000},"page":"61-76","source":"Crossref","is-referenced-by-count":161,"title":["Site-Specific PEGylation of Protein Disulfide Bonds Using a Three-Carbon Bridge"],"prefix":"10.1021","volume":"18","author":[{"given":"Sibu","family":"Balan","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, The School of Pharmacy, University of London, 29\/39 Brunswick Square, London WC1N 1AX, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Ducane Road, London W12 0NN, and Department of Pharmaceutical and Biological Chemistry, The School of Pharmacy, University of London, 29\/39 Brunswick Square, London WC1N 1AX, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-won","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, The School of Pharmacy, University of London, 29\/39 Brunswick Square, London WC1N 1AX, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Ducane Road, London W12 0NN, and Department of Pharmaceutical and Biological Chemistry, The School of Pharmacy, University of London, 29\/39 Brunswick Square, London WC1N 1AX, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Godwin","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, The School of Pharmacy, University of London, 29\/39 Brunswick Square, London WC1N 1AX, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Ducane Road, London W12 0NN, and Department of Pharmaceutical and Biological Chemistry, The School of Pharmacy, University of London, 29\/39 Brunswick Square, London WC1N 1AX, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Teo","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, The School of Pharmacy, University of London, 29\/39 Brunswick Square, London WC1N 1AX, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Ducane Road, London W12 0NN, and Department of Pharmaceutical and Biological Chemistry, The School of Pharmacy, University of London, 29\/39 Brunswick Square, London WC1N 1AX, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos M.","family":"Laborde","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, The School of Pharmacy, University of London, 29\/39 Brunswick Square, London WC1N 1AX, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Ducane Road, London W12 0NN, and Department of Pharmaceutical and Biological Chemistry, The School of Pharmacy, University of London, 29\/39 Brunswick Square, London WC1N 1AX, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Heidelberger","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, The School of Pharmacy, University of London, 29\/39 Brunswick Square, London WC1N 1AX, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Ducane Road, London W12 0NN, and Department of Pharmaceutical and Biological Chemistry, The School of Pharmacy, University of London, 29\/39 Brunswick Square, London WC1N 1AX, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mire","family":"Zloh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, The School of Pharmacy, University of London, 29\/39 Brunswick Square, London WC1N 1AX, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Ducane Road, London W12 0NN, and Department of Pharmaceutical and Biological Chemistry, The School of Pharmacy, University of London, 29\/39 Brunswick Square, London WC1N 1AX, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Shaunak","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, The School of Pharmacy, University of London, 29\/39 Brunswick Square, London WC1N 1AX, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Ducane Road, London W12 0NN, and Department of Pharmaceutical and Biological Chemistry, The School of Pharmacy, University of London, 29\/39 Brunswick Square, London WC1N 1AX, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Brocchini","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, The School of Pharmacy, University of London, 29\/39 Brunswick Square, London WC1N 1AX, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Ducane Road, London W12 0NN, and Department of Pharmaceutical and Biological Chemistry, The School of Pharmacy, University of London, 29\/39 Brunswick Square, London WC1N 1AX, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2006,11,29]]},"reference":[{"issue":"3","key":"bc0601471b00001\/bc0601471b00001_1","doi-asserted-by":"crossref","DOI":"10.1038\/nrd1033","volume":"2","author":"Harris J.","year":"2003","journal-title":"Nat. Rev. Drug Discovery"},{"key":"bc0601471b00002\/bc0601471b00002_1","doi-asserted-by":"crossref","DOI":"10.1016\/0169-409X(95)00023-Z","volume":"16","author":"Zalipsky S.","year":"1995","journal-title":"Adv. Drug Delivery Rev."},{"key":"bc0601471b00003\/bc0601471b00003_1","doi-asserted-by":"crossref","DOI":"10.1016\/S0169-409X(02)00180-1","volume":"55","author":"Greenwald R.","year":"2003","journal-title":"Adv. Drug Delivery Rev."},{"issue":"5","key":"bc0601471b00004\/bc0601471b00004_1","first-page":"36","volume":"14","author":"Pasut G.","year":"2004","journal-title":"Expert Opin. Ther. Pat."},{"key":"bc0601471b00005\/bc0601471b00005_1","volume-title":"PEGylation, successful approach to drug delivery. Drug Discovery Today 10 (21), 1451\u22121458","author":"Veronese F.","year":"2005"},{"issue":"8","key":"bc0601471b00006\/bc0601471b00006_1","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M412134200","volume":"280","author":"Grace M.","year":"2005","journal-title":"J. Biol. Chem."},{"key":"bc0601471b00007\/bc0601471b00007_1","volume-title":"Protected thio-poly(ethylene glycol):\u2009 A new activated polymer for reversible protein modification. Bioconjugate Chem. 4 (5), 314\u2212318","author":"Woghiren C.","year":"1993"},{"key":"bc0601471b00008\/bc0601471b00008_1","volume-title":"Characterization and stability of N-terminally PEGylated rhG-CSF. Pharm. Res. 13 (7), 996\u22121002","author":"Kinstler O.","year":"1996"},{"issue":"4","key":"bc0601471b00009\/bc0601471b00009_1","doi-asserted-by":"crossref","DOI":"10.1016\/S0169-409X(02)00023-6","volume":"54","author":"Kinstler O.","year":"2002","journal-title":"Adv. Drug Delivery Rev."},{"key":"bc0601471b00010\/bc0601471b00010_1","doi-asserted-by":"crossref","DOI":"10.1016\/S0169-409X(02)00026-1","volume":"54","author":"Chapman A.","year":"2002","journal-title":"Adv. Drug Delivery Rev."},{"key":"bc0601471b00011\/bc0601471b00011_1","volume-title":"Carboxyalkylated histidine is a pH-dependent product of pegylation with SC-PEG. Pharm. Res. 18, 1354\u22121360","author":"Wylie D.","year":"2001"},{"key":"bc0601471b00012\/bc0601471b00012_1","volume-title":"Site-specific PEGylation of hemoglobin at cys-93:\u2009 Correlation between the colligative properties of the PEGylated protein and the length of the conjugated PEG chain. Bioconjugate Chem. 14, 464\u2212472","author":"Manjula B.","year":"2003"},{"key":"bc0601471b00013\/bc0601471b00013_1","volume-title":"N-terminal site-specific mono-PEGylation of epidermal growth factor. Pharm. Res. 20 (5), 818\u2212825","author":"Lee H.","year":"2003"},{"key":"bc0601471b00014\/bc0601471b00014_1","volume-title":"Site-specific PEGylation of a lysine-deficient TNF-alpha with full bioactivity. Nat. Biotechnol. 21, 546\u2212552","author":"Yamamoto Y.","year":"2003"},{"key":"bc0601471b00015\/bc0601471b00015_1","volume-title":"Direct production of proteins with N-terminal cysteine for site-specific conjugation. Bioconjugate Chem. 15, 658\u2212663","author":"Gentle I.","year":"2004"},{"issue":"10","key":"bc0601471b00016\/bc0601471b00016_1","doi-asserted-by":"crossref","DOI":"10.1016\/S0169-409X(03)00112-1","volume":"55","author":"Edwards C.","year":"2003","journal-title":"Adv. Drug Delivery Rev."},{"key":"bc0601471b00017\/bc0601471b00017_1","volume-title":"Transflutaminase-mediated dual and site-specific incorporation of poly(ethylene glycol) derivatives into a chimeric interleukin-2. Bioconjugate Chem. 11, 502\u2212509","author":"Sato H.","year":"2000"},{"key":"bc0601471b00018\/bc0601471b00018_1","doi-asserted-by":"crossref","DOI":"10.1016\/S0169-409X(02)00024-8","volume":"54","author":"Sato H.","year":"2002","journal-title":"Adv. Drug Delivery Rev."},{"key":"bc0601471b00019\/bc0601471b00019_1","volume-title":"A long-acting, highly potent interferon a-2 conjugate created using site-specific PEGylation. Bioconjugate Chem. 16, 200\u2212207","author":"Rosendahl M.","year":"2005"},{"key":"bc0601471b00020\/bc0601471b00020_1","volume-title":"Recombinant protein therapeutics- success rates, market trends and values to","author":"Pavlou A.","year":"2004"},{"key":"bc0601471b00021\/bc0601471b00021_1","doi-asserted-by":"crossref","DOI":"10.1016\/0022-2836(81)90515-5","volume":"151","author":"Thornton J.","year":"1981","journal-title":"J. Mol. Biol."},{"key":"bc0601471b00022\/bc0601471b00022_1","volume-title":"Amino acid neighbours and detailed conformational analysis of cysteines in proteins. Protein Eng. 12 (7), 535\u2212548","author":"Petersen M.","year":"1999"},{"key":"bc0601471b00023\/bc0601471b00023_1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1399-3011.2004.00189.x","volume":"65","author":"Leung H.","year":"2005","journal-title":"J. Peptide Res."},{"key":"bc0601471b00024\/bc0601471b00024_1","volume-title":"Disulfide bonds and the stability of globular proteins. Protein Sci. 2, 1551\u22121558","author":"Betz S.","year":"1993"},{"key":"bc0601471b00025\/bc0601471b00025_1","volume-title":"Polarity of disulfide bonds. Protein Sci. 2, 1183\u22121184","author":"Saunders A.","year":"1993"},{"key":"bc0601471b00026\/bc0601471b00026_1","volume-title":"Human pituitary growth hormone. Physicochemical investigations of the native and reduced-alkylated protein. Biochemistry 8 (12), 4701\u22124708","author":"Bewley T.","year":"1969"},{"key":"bc0601471b00027\/bc0601471b00027_1","volume-title":"Disulfide bonds and protein folding. Biochemistry 39, 4207\u22124216","author":"Wedemeyer W.","year":"2000"},{"key":"bc0601471b00028\/bc0601471b00028_1","volume-title":"Disulfide bridges in interleukin-8 probed using nono-natural disulfide analogues:\u2009 dissociation of roles in structure from function. Biochemistry 38, 7653\u22127658","author":"Rajarathnam K.","year":"1999"},{"key":"bc0601471b00029\/bc0601471b00029_1","volume-title":"Phospholipase A2 engineering. The roles of disulfide bonds in structure, conformational stability, and catalytic function? Biochemistry 34, 15307\u221215314","author":"Zhu H.","year":"1995"},{"key":"bc0601471b00030\/bc0601471b00030_1","volume-title":"Roles of the 29-138 disulfide bond of subtype A of human a interferon in its antiviral activity and conformational stability. Biochemistry 23, 2500\u22122507","author":"Morehead H.","year":"1984"},{"key":"bc0601471b00031\/bc0601471b00031_1","doi-asserted-by":"crossref","DOI":"10.1016\/0014-5793(75)80726-5","volume":"60","author":"Todokoro K.","year":"1975","journal-title":"FEBS Lett."},{"key":"bc0601471b00032\/bc0601471b00032_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00214-006-0134-0"},{"key":"bc0601471b00033\/bc0601471b00033_1","volume-title":"Site-specific PEGylation of native disulfide bonds in therapeutic proteins. Nat. Chem. Biol 2, 312\u2212313","author":"Shaunak S.","year":"2006"},{"key":"bc0601471b00034\/bc0601471b00034_1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0022-1759(01)00460-4","volume":"257","author":"Meager A.","year":"2001","journal-title":"J. Immunol. Methods"},{"key":"bc0601471b00035\/bc0601471b00035_1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/bc00001a005","volume":"1","author":"Liberatore F.","year":"1990","journal-title":"Bioconjugate Chem."},{"key":"bc0601471b00036\/bc0601471b00036_1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1021\/bc00001a008","volume":"1","author":"de Rosario R.","year":"1990","journal-title":"Bioconjugate Chem."},{"key":"bc0601471b00037\/bc0601471b00037_1","doi-asserted-by":"crossref","DOI":"10.1021\/jo00008a014","volume":"56","author":"Burns J.","year":"1991","journal-title":"J. Org. Chem."},{"key":"bc0601471b00038\/bc0601471b00038_1","volume-title":"Refolding of low molecular weight urokinase plasminogen activator by dilution and size exlusion chromatography. A comparative study. Sep. Sci. Technol. 35 (11), 1743\u22121760","author":"Fahey E.","year":"2000"},{"key":"bc0601471b00039\/bc0601471b00039_1","doi-asserted-by":"crossref","DOI":"10.1051\/epn\/19861701011","volume-title":"NMR of the Proteins and Nucleic Acids","author":"W\u00fcthrich K.","year":"1986"},{"key":"bc0601471b00040\/bc0601471b00040_1","volume":"65","author":"Bax A.","year":"1985","journal-title":"J. Magn. Reson."},{"key":"bc0601471b00041\/bc0601471b00041_1","doi-asserted-by":"crossref","DOI":"10.1063\/1.438208","volume":"71","author":"Jeener J.","year":"1979","journal-title":"J. Chem. Phys."},{"key":"bc0601471b00042\/bc0601471b00042_1","volume-title":"Tumor inhibitory effect of l-asparaginase from Escherichia coli. Arch. Biochem. Biophys. 105, 450\u2212452","author":"Mashburn L.","year":"1964"},{"key":"bc0601471b00043\/bc0601471b00043_1","doi-asserted-by":"crossref","DOI":"10.1016\/S0378-5173(02)00046-7","volume":"237","author":"Soares A.","year":"2002","journal-title":"Int. J. Pharm."},{"key":"bc0601471b00044\/bc0601471b00044_1","doi-asserted-by":"crossref","DOI":"10.1002\/jcc.540110405","volume":"11","author":"Mohamadi F.","year":"1990","journal-title":"J. Comput. Chem."},{"key":"bc0601471b00045\/bc0601471b00045_1","doi-asserted-by":"crossref","DOI":"10.1021\/ja9621760","volume":"118","author":"Jorgensen W.","year":"1996","journal-title":"J. Am. Chem. Soc."},{"issue":"16","key":"bc0601471b00046\/bc0601471b00046_1","doi-asserted-by":"crossref","DOI":"10.1021\/ja00172a038","volume":"112","author":"Still W.","year":"1990","journal-title":"J. Am. Chem. Soc."},{"key":"bc0601471b00047\/bc0601471b00047_1","doi-asserted-by":"crossref","DOI":"10.1107\/S0567739482001806","volume":"38","author":"McLachlan A.","year":"1982","journal-title":"Acta Crystallogr., Sect. A"},{"key":"bc0601471b00048\/bc0601471b00048_1","volume-title":"Profit, version 1.8","author":"Martin A.","year":"2005"},{"issue":"11","key":"bc0601471b00049\/bc0601471b00049_1","doi-asserted-by":"crossref","DOI":"10.1021\/ja00505a043","volume":"101","author":"Mitra S.","year":"1979","journal-title":"J. Am. Chem. Soc."},{"key":"bc0601471b00050\/bc0601471b00050_1","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1021\/ja00223a061","volume":"110","author":"Brocchini S.","year":"1988","journal-title":"J. Am. Chem. Soc."},{"key":"bc0601471b00051\/bc0601471b00051_1","doi-asserted-by":"crossref","unstructured":"Wilbur, D., Stray, J., Hamlin, D., Curtis, D., and Vessella, R. (1994) Monoclonal antibody Fab\u2018 fragment cross-linking using equilibrium transfer alkylation reagents. A strategy for site-specific conjugation of diagnostic and therapeutic agents with F(ab\u2018)2 fragments.Bioconjugate Chem.5, 220\u2212235.","DOI":"10.1021\/bc00027a007"},{"key":"bc0601471b00052\/bc0601471b00052_1","volume-title":"Tin-free radical-mediated C-C bond formations with alkyl allyl sulfones as radical precursors","author":"Kim S.","year":"2002"},{"key":"bc0601471b00053\/bc0601471b00053_1","volume-title":"Synthesis via vinyl sulfones. 34. Sn2\u2018 additions of cuprates to sulfone and ester-polarized cyclopentenylic systems. Tetrahedron 45 (2), 467\u2212478","author":"Pan Y.","year":"1989"},{"issue":"1","key":"bc0601471b00054\/bc0601471b00054_1","doi-asserted-by":"crossref","DOI":"10.1002\/hlca.19840670133","volume":"67","author":"Seebach D.","year":"1984","journal-title":"Helv. Chim. Acta"},{"issue":"16","key":"bc0601471b00055\/bc0601471b00055_1","doi-asserted-by":"crossref","DOI":"10.1021\/ja00968a054","volume":"88","author":"Nelson R.","year":"1966","journal-title":"J. Am. Chem. Soc."},{"key":"bc0601471b00056\/bc0601471b00056_1","volume":"57","author":"Padwa A.","year":"1992","journal-title":"J. Org. Chem."},{"key":"bc0601471b00057\/bc0601471b00057_1","unstructured":"Casey, J., Pedley, R., King, D., Boden, R., Chapman, A., Yarranton, G., and Begent, R. (2000) Improved tumour targeting of di-Fab\u2018 fragments modified with polyethylene glycol.Tumor Targeting4, 235\u2212244."},{"key":"bc0601471b00058\/bc0601471b00058_1","volume-title":"Reaction of Tris(2-carboxyethyl)phosphine (TCEP) with Maleimide and a-Haloacyl Groups:\u2009 Anomalous Elution of TCEP by Gel Filtration. Anal. Biochem. 282, 161\u2212164","author":"Shafer D.","year":"2000"},{"key":"bc0601471b00059\/bc0601471b00059_1","volume":"245","author":"Ho P.","year":"1970","journal-title":"J. Biol. Chem."},{"key":"bc0601471b00060\/bc0601471b00060_1","volume-title":"Proc. Natl. Acad. Sci. U.S.A. 90","author":"Swain A.","year":"1993"},{"key":"bc0601471b00061\/bc0601471b00061_1","doi-asserted-by":"crossref","DOI":"10.1016\/0014-5793(96)00660-6","volume":"390","author":"Palm G.","year":"1996","journal-title":"FEBS Lett."},{"key":"bc0601471b00062\/bc0601471b00062_1","volume-title":"Hypersensitive reactions and antibody formation during l-asparaginase treatment of children and adults with acute leukemia. Cancer 37, 220\u2212228","author":"Killander D.","year":"1976"},{"key":"bc0601471b00063\/bc0601471b00063_1","volume":"216","author":"Kamisaki Y.","year":"1981","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"bc0601471b00064\/bc0601471b00064_1","volume":"77","author":"Yoshimoto T.","year":"1986","journal-title":"Jpn. J. Cancer Res."},{"key":"bc0601471b00065\/bc0601471b00065_1","volume-title":"Rational design of a potent, long-lasting form of interferon:\u2009 A 40 kDa branched polyethylene glycol-conjugated interferon \u03b1-2a for the treatment of Hepatitis C. Bioconjugate Chem. 12, 195\u2212202","author":"Bailon P.","year":"2001"},{"key":"bc0601471b00066\/bc0601471b00066_1","doi-asserted-by":"crossref","DOI":"10.1089\/107999001317205240","volume":"21","author":"Grace M.","year":"2001","journal-title":"J. Interferon Cytokine Res."},{"key":"bc0601471b00067\/bc0601471b00067_1","volume":"54","author":"Rajender R.","year":"2002","journal-title":"Adv. Drug Delivery Rev."},{"key":"bc0601471b00068\/bc0601471b00068_1","volume-title":"Structure, biology, and therapeutic implications of pegylated interferon alpha-2b. Curr. Pharm. Des. 8, 2139\u22122157","author":"Youngster S.","year":"2002"},{"key":"bc0601471b00069\/bc0601471b00069_1","doi-asserted-by":"crossref","unstructured":"Dhalluin, C., Ross, A., Huber, W., Gerber, P., Brugger, D., Gsell, B., and Senn, H. (2005) Structural, kinetic, and thermodynamic analysis of the binding of the 40 kDa PEG-interferon-alpha 2a and its individual positional isomers to the extracellular domain of the receptor IFNAR2.Bioconjugate Chem.16, 518\u2212527.","DOI":"10.1021\/bc049780h"},{"key":"bc0601471b00070\/bc0601471b00070_1","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M006854200","volume":"275","author":"Piehler J.","year":"2000","journal-title":"J. Biol. Chem."},{"key":"bc0601471b00071\/bc0601471b00071_1","volume-title":"Protein PEGylation decreases observed target association rates via a dual blocking mechanism. Mol. Pharmacol. 68, 1439\u22121454","author":"Kubetzko S.","year":"2005"},{"key":"bc0601471b00072\/bc0601471b00072_1","volume-title":"Structural and biophysical characterization of the 40 kDa PEG-interferon-\u03b12a and its individual positional isomers. Bioconjugate Chem. 16, 504\u2212517","author":"Dhalluin C.","year":"2005"}],"container-title":["Bioconjugate Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/bc0601471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T15:53:52Z","timestamp":1707407632000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/bc0601471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,29]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1,1]]}},"alternative-id":["10.1021\/bc0601471"],"URL":"https:\/\/doi.org\/10.1021\/bc0601471","relation":{},"ISSN":["1043-1802","1520-4812"],"issn-type":[{"value":"1043-1802","type":"print"},{"value":"1520-4812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,29]]}}}